NCT07138287 Concerned Growth Factor VS Miniral Trioide Aggregate in Treatment of Mature Permanent Teeth of Children With Symptomatic Irreversible Pulpitis.
| NCT ID | NCT07138287 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Minia University |
| Condition | Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar With Irreversible Pulpitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-07-11 |
| Primary Completion | 2025-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-07-11 with a primary completion date of 2025-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Concerned Growth factor versus Miniral Trioide aggregate in management of Mature permanent Molar of children with irreversible pulpitis
Eligibility Criteria
Inclusion Criteria: Permanent Molar with closed Apex and diagnosed with irreversible pulpitis \- Exclusion Criteria: * medically compromised children. * non restorable tooth * Necrotic tooth
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07138287 clinical trial?
This trial is open to participants of all sexes, aged 9 Years or older, up to 16 Years, studying Concerned Growth Factor Versus Miniral Trioide Aggregate in Management of Mature Permanent Molar With Irreversible Pulpitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07138287 currently recruiting?
Yes, NCT07138287 is actively recruiting participants. Contact the research team at mahmoudmostafa100001@gmail.com for enrollment information.
Where is the NCT07138287 trial being conducted?
This trial is being conducted at Minya, Egypt.
Who is sponsoring the NCT07138287 clinical trial?
NCT07138287 is sponsored by Minia University. The trial plans to enroll 200 participants.